4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001780649-25-000002
CEO and Chairman sold 89,265 shares at an average $14.73 ($1,315,180)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROBINS CHAD M · CEO and Chairman
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-11-10 | Sale : show line 1 in the form 10b5-1 | −86,161 | $14.73 | $1,269,152 | 2,873,088 | D |
| 2025-11-11 | Sale : show line 2 in the form 10b5-1 | −1,237 | $14.57 | $18,023 | 2,871,851 | D |
| 2025-11-12 | Sale : show line 3 in the form 10b5-1 | −1,867 | $15.00 | $28,005 | 2,869,975 | D |
| Open-market sales · 89,265 sh · avg $14.73 · $1,315,180 | ||||||
Loading xslF345X05/primary_doc.xml…